Skip to content

Clinical trials

Hematologic Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Country / region: Taiwan Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20122
20131
20141
20151
20171
20186
20192
20204
20214
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting7
Terminated2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
BioMarin Pharmaceutical4
Pfizer3
Abbott Medical Devices2
Genzyme, a Sanofi Company2
National Taiwan University Hospital2
Amgen1
Ariad Pharmaceuticals1
Celgene1
Chang Gung Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases27
Hemophilia A8
Blood Coagulation Disorders, Inherited7
Coagulation Protein Disorders7
Genetic Diseases, Inborn7
Hemorrhagic Disorders7
Blood Coagulation Disorders6
Bone Marrow Diseases6
Hemostatic Disorders6
Lymphoma, Non-Hodgkin6

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.